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Abstract
Objective To investigate the agreement between direct and indirect
comparisons of competing healthcare interventions.
Design Meta-epidemiological study based on sample of meta-analyses
of randomised controlled trials.
Data sources Cochrane Database of Systematic Reviews and PubMed.
Inclusion criteria Systematic reviews that provided sufficient data for
both direct comparison and independent indirect comparisons of two
interventions on the basis of a common comparator and in which the
odds ratio could be used as the outcome statistic.
Main outcome measure Inconsistency measured by the difference in
the log odds ratio between the direct and indirect methods.
Results The study included 112 independent trial networks (including
1552 trials with 478 775 patients in total) that allowed both direct and
indirect comparison of two interventions. Indirect comparison had already
been explicitly done in only 13 of the 85 Cochrane reviews included.
The inconsistency between the direct and indirect comparison was
statistically significant in 16 cases (14%, 95% confidence interval 9% to
22%). The statistically significant inconsistency was associated with
fewer trials, subjectively assessed outcomes, and statistically significant
effects of treatment in either direct or indirect comparisons. Owing to
considerable inconsistency, many (14/39) of the statistically significant
effects by direct comparison became non-significant when the direct
and indirect estimates were combined.
Conclusions Significant inconsistency between direct and indirect
comparisons may be more prevalent than previously observed. Direct
and indirect estimates should be combined in mixed treatment
comparisons only after adequate assessment of the consistency of the
evidence.
Introduction
Randomised controlled trials to compare competing
interventions are often lacking, and this situation is unlikely to
improve in the future because of the inevitable tension between
the high cost of clinical trials and the continuing introduction
of new treatments.
1 2 The dearth of evidence from head to head
randomised controlled trials has led to increased use of indirect
comparison methods to estimate the comparative effects of
treatment.
1-4
Indirectcomparisonofcompetinginterventionscanbegenerally
defined as a comparison of different treatments for a clinical
indication by using data from separate randomised controlled
trials, in contrast to direct comparison within randomised
controlled trials. Indirect comparison based on a common
comparator can preserve certain strengths of randomised
allocation of patients for estimating comparative effects of
treatment.
1 5 6 The term “adjusted indirect comparison” is used
to refer to this indirect comparison based on a common
intervention (fig 1).
7 Mixed treatment comparison (also known
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Research
RESEARCHas network meta-analysis or multiple treatment meta-analysis)
isamorecomplexmethodthatcombinesbothindirectanddirect
estimates simultaneously.
8-10 The validity of indirect and mixed
treatment comparisons depends on certain basic assumptions
that are similar to but more complex than assumptions
underlying standard meta-analysis.
1 3
Thevalidityofadjustedindirectcomparisonhasbeenpreviously
investigated by systematically comparing results of adjusted
indirect comparison and direct comparison by using data from
publishedmeta-analyses.
7 11Thelimitedevidenceindicatedthat
differences between direct and adjusted indirect comparisons
were only occasionally statistically significant (3/44).
7 The
objective of this study was to update our previous work by
refining the methods used and increasing the number of cases
included.
7
Methods
Inclusion and exclusion criteria
Weincludedsystematicreviewsormeta-analysesofrandomised
controlledtrialsthatprovidedsufficientdataforbothdirectand
indirect comparison of two interventions (A and B). Using data
from the included systematic reviews, we constructed trial
networkssothatinterventionsAandBcouldbecomparedboth
directly and indirectly (fig 1). Each trial network is a simple
loop of evidence, consisting of three sets of independent
randomised controlled trials: one for the direct comparison of
A versus B and two for the indirect comparison of A versus B
with C as the common comparator. We included all reviews
that provided sufficient data, whether or not the indirect
comparison was done in the original analysis.
In a trial network, interventions A and B are the two active
interventions we would like to compare, and the common
intervention C may be a placebo or no-treatment intervention.
In some included trial networks, all three interventions were
active interventions so that the common comparator must also
be an active treatment. In these cases, we selected the
comparisonthatprovidedthemostpreciseestimateasthedirect
comparison (that is, the smallest standard error among the
possibledirectcomparisons).Thisdecisionmeansthatthedirect
comparison will be more likely to be statistically significant,
but it has no effect on the absolute inconsistency between the
direct and indirect comparison.
The use of odds ratios for binary outcomes is associated with
less heterogeneity in meta-analysis than is the use of risk
differences or relative risks,
12 and possible inferential fallacies
exist when relative risk is used in indirect comparison.
13
Therefore,weincludedonlycasesinwhichtheoddsratiocould
be used as the outcome statistic.
When we found multiple systematic reviews or meta-analyses
on the same topic, we included only the most recent
meta-analyses with the largest number of included trials. We
excluded meta-analyses in which the odds ratio could not be
used as the outcome statistic. We included three arm trials
(comparing interventions A, B, and C within the same
randomised controlled trials) only for the direct comparison of
interventions A and B.
Identification of relevant trial networks
We identified most relevant cases by scanning all Cochrane
systematic reviews revised or published between January 2000
and October 2008. We obtained the titles and abstracts of all
completed Cochrane systematic reviews of interventions from
the Cochrane Database of Systematic Reviews (issue 3, 2008).
One reviewer (SPB) scanned these titles and abstracts, and two
reviewers (YKL and FS) assessed full publications of the
identified possibly relevant reviews. If the indirect comparison
was not explicitly done in the original review, we checked
information provided in the review to identify apparent reasons
why the indirect comparison was clearly inappropriate. We
resolved any uncertain cases by discussion.
We also searched PubMed in October 2008 for systematic
reviewsormeta-analysespublishedsince2000inwhichindirect
comparison had been explicitly used (see appendix 1 in Song
et al 2009 for the search strategy
3). We identified additional
independent cases from previous published studies.
7 11
Data extraction
We extracted the following information from the included
systematicreviews:diseasecategories,interventionscompared,
outcomes measured, number of trials and patients, and results
of trials included in meta-analyses. One reviewer did the data
extraction,andasecondreviewercheckedit.Anydisagreements
were resolved by discussion or the involvement of a third
reviewer if necessary.
Data analysis methods
We used Bucher et al’s method to do adjusted indirect
comparisons.
5Wepooledresultsfromindividualtrialsbyusing
random effects, inverse variance, weighted meta-analysis
(DerSimonian-Lairdmethod
14).Wecalculatedtheinconsistency,
defined as the difference in log odds ratios between direct and
indirect estimates, together with its standard error, and tested
whether the inconsistency was statistically significant. The
inconsistency between direct and indirect estimates can also be
expressed as a ratio of odds ratios by an antilog transformation.
Web appendix 1 gives the calculation methods and formulas
used, with a practical example.
Wecalculatedtheproportionoftrialnetworkswithastatistically
significant inconsistency (P<0.05) between the direct and
indirect comparisons. We did pre-specified subgroup analyses
to investigate the association of a significant inconsistency and
certain characteristics of the comparison: source of trial
networks, type of common comparators, nature of the two
interventions compared, total number of trials, extent of
heterogeneity in meta-analysis, whether the outcome was
subjectively or objectively assessed, and the results of direct or
indirect comparisons. We used the χ
2 test or Fisher’s exact test
to statistically assess the difference between subgroups when
the expected value was lower than 5.
To examine the effect of random error, we plotted the absolute
value of inconsistency against the inverse of its standard error
in a one sided funnel plot. We used the absolute value of
inconsistency because it would usually be arbitrary to decide
which of the two interventions being compared was the main
treatment of interest (notated as A in the above equations) and
which was considered as the active comparator (notated as B).
In trial networks that compared a newer or more intense
intervention to an older or less intense intervention, we
considered the first to be intervention A and the second to be
interventionB.Therefore,thesign(ordirection)ofinconsistency
between the direct and indirect estimates indicates whether the
indirectcomparisonshaveoverestimatedorunderestimatedthe
treatment effects compared with the direct comparison. For
these trial networks, we used a conventional funnel plot to
examine the possible small study effect (Egger’s regression
method).
15
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RESEARCHResults
After assessing the abstracts of 3319 Cochrane systematic
reviewscompletedbyOctober2008,weidentified223reviews
thatwerepossiblyrelevant.Wethenexaminedfullpublications
of these 223 Cochrane reviews and included 85 independent
trial networks that met the inclusion criteria. From 745
references retrieved from searching PubMed in October 2008,
we included 12 systematic reviews that contained 17
independent trial networks. We also identified 10 additional
trial networks from previous studies.
7 11 In total, we included
112independenttrialnetworks.Webappendix2showsexcluded
cases with reasons for exclusion.
Web appendix 3 summarises the main characteristics of the
included trial networks. The included trial networks evaluated
interventions for a wide range of clinical indications (table 1).
Ninety-nineofthe112trialnetworksevaluateddrugtreatments.
In total, 473 trials (with 141 363 patients) contributed data for
the direct comparisons. The adjusted indirect comparisons
involved 1079 trials (with 337 412 patients) (table 1). The
number of trials ranged from one to 18 (median 3) per direct
comparisonandfromtwoto65(median6)peradjustedindirect
comparison.
Inconsistency between direct and indirect
estimates
Figure 2 shows observed inconsistencies (ratio of odds ratios
and 95% confidence intervals) between direct and indirect
comparisons. The direction of the ratio of odds ratios has no
clinical meaning in many instances owing to the arbitrary
labelling of interventions as A and B.
Of the 112 included trial networks, the inconsistency between
the direct and indirect comparison was statistically significant
(P<0.05)in16cases(14%,95%confidenceinterval9%to22%).
All16casesofsignificantinconsistencywerefromtheCochrane
reviews (table 2). We found no significant difference in the
frequency of significant inconsistency between subgroups
according to the common comparator used, the nature of the
two interventions (A and B) compared, or whether indirect
comparisons had been explicitly done in the original Cochrane
reviews(table2).However,statisticallysignificantinconsistency
was associated with fewer randomised controlled trials
(P=0.006), subjectively assessed outcomes (P=0.029), and
statistically significant estimates of treatment effects by either
direct or indirect comparison (P<0.001). The extent of
heterogeneityinmeta-analyseswasalsostatisticallysignificantly
associated with the inconsistency (P=0.018), which seemed to
be at least partly a result of confounding by the small number
of primary studies (table 2).
Thirty-nine (35%) of the 112 direct comparisons showed
statistically significant results in favour of an intervention, but
only 13 indirect comparisons gave the same results as the
corresponding direct comparisons (table 3). In one case, the
adjusted indirect comparison gave a significant result that was
opposite to that of the direct comparison (see web appendix 1
fordetails).Whenwecombinedthedirectandindirectestimates,
14 of the 39 statistically significant direct estimates were no
longer statistically significant and only three of the 73
non-significant direct estimates became statistically significant
(table 3).
The shape of the one sided funnel plot indicates that the
observed inconsistency between the direct and indirect
comparisonscouldbeexplainedtosomeextentbyrandomerror
(fig 3). However, we would expect approximately 5% of the
pointstolietotherightofthedottedline,whereasactually14%
do.
In 65 trial networks that compared a newer or more intense
intervention with an older or less intense intervention, the sign
(ordirection)oftheinconsistencybetweenthedirectandindirect
estimates indicates whether the indirect comparisons have
overestimated or underestimated the effects of treatment
compared with the direct comparison. Figure 4 is a funnel plot
of observed discrepancies between the direct and indirect
comparison in these 65 cases. The funnel plot is visually
symmetrical (Egger’s test, P=0.37). The pooled inconsistency
(ratio of odds ratios) from the 65 cases was 0.90 (95%
confidence interval 0.76 to 1.06; P=0.22), indicating that,
overall,thedifferencebetweenthedirectandindirectestimates
was not statistically different.
Discussion
Our findings indicate that significant inconsistency between
direct and indirect comparisons of competing healthcare
interventions may be more prevalent than previously observed
andmaybemorecommonwithsubjectivelyassessedoutcomes,
fewer trials included in analyses, and statistically significant
resultsfromeitherdirectorindirectcomparison.Theproportion
of cases with statistically significant inconsistency (P<0.05)
between the direct and indirect comparison observed in this
study was 14%, much higher than the expected 5% (statistical
significance α=0.05) and higher than that found in a previous
study (7%).
7
Inconsistencybetweenthedirectandindirectcomparisonsmay
be explained by the play of chance, bias in the direct or indirect
comparison, and clinically meaningful heterogeneity.
3 The
funnel plot in this study shows that the effect of random error
is apparent; the points of inconsistency (ratio of odds ratios)
with less precise estimates were much more widely scattered
(fig 3). We found that statistical inconsistency was associated
with subjectively assessed outcomes, which may be because of
the greater risk of bias in trials with subjectively assessed
outcomes.
16
Trial networks with fewer randomised controlled trials are
expected to have wider confidence intervals, so statistically
significant inconsistency should be less likely. However,
statistically significant results were not associated with the
number of trials in the trial networks included. The proportion
of statistically significant results from either direct or indirect
comparisonswas42%intrialnetworksthatincludedonlythree
to five randomised controlled trials (with a median sample size
of 89 per trial), and it was 43% in trial networks that included
six or more randomised controlled trials (with a median sample
size of 138 per trial). Therefore, the association between
significantinconsistencyandfewerrandomisedcontrolledtrials
may be partly due to the “small study effect.” Small trials are
suspected to be more vulnerable to the biased selection of
positive results for publication.
17
As between study heterogeneity increases, so does the
uncertaintyintheestimatedeffectsoftreatment.Thisincreased
uncertainty means that statistically significant inconsistency is
less likely to be detected. We found zero heterogeneity (I
2=0)
in a large number of trial networks (20/26) that included only
three to five primary studies in total (table 2). Because of the
small number of studies involved in many trial networks, data
from this study are insufficient to show a clear pattern of
association between the extent of heterogeneity and statistical
inconsistency between the direct and indirect estimates.
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bias (from methodological flaws) in clinical trials is associated
with an exaggerated effect of treatment.
16 18 19 Previous studies
foundthatthetreatmenteffectsofnewdrugstendedtobegreater
when assessed by direct comparisons than with the adjusted
indirect comparisons, possibly as a result of “optimism bias”
or “novel agent effects.”
20 21 In this study, among the trial
networks that compared a newer or more intense intervention
with an older or less intense intervention we saw no systematic
differences between the direct and indirect comparisons (table
2). Deciding accurately which treatment was newer or more
intense is often difficult. For the practical example in web
appendix 1, we were initially unable to decide which of the two
treatments was newer according to information provided in the
review.
22 By examining the full text of the primary paper,
23 we
found that the single direct comparison trial aimed to compare
“anovel”or“newlydeveloped”15%gelformulationofazelaic
acid and a conventional 0.75% metronidazole gel for the
treatment of rosacea.
Statisticallysignificantestimatesofeffectsoftreatmentineither
directorindirectcomparisonsmaybeexpectedtobeassociated
with higher prevalence of statistical inconsistency. As in the
previous study,
7 the indirect comparison produced fewer
statistically significant results than did the direct comparison
(table 3). When all three interventions in a trial network were
active interventions, we selected A and B according to the
estimates’ precision, which might have contributed to the
observation of more statistically significant results from the
direct comparisons. Given the same sample size, the direct
comparison has been established to be four times more precise
than the adjusted indirect comparison.
1
Implications, strengths, and limitations of
study
An indirect comparison had not been done in most (72/85)
Cochrane reviews that provided sufficient data for both direct
and indirect comparisons. The proportion of statistical
inconsistency was higher in cases that did not do indirect
comparisons than in those with explicit indirect comparisons
(21% v 8%), although the difference was not statistically
significant (P=0.45). If authors of systematic reviews did not
do or report the indirect comparison because of perceived
inconsistency, we may have overestimated the prevalence of
statistical inconsistency in our study. However, no reason was
given in reviews as to why an indirect comparison had not been
done despite sufficient data being available. We anticipate that
the use of indirect comparison will spread over time as more
authors become aware of the available methods for indirect
comparisons.
According to our knowledge, this study included the largest
number of independent trial networks to investigate the
inconsistencybetweendirectandindirectcomparisons.Although
this study included 112 trial networks in total, the number of
included trials and patients within individual networks was
rather small in most cases, and the available evidence was
limited for exploratory subgroup analyses.
Becausewemayobservesomedisagreementbetweenthedirect
andindirectestimatespurelybychance,weusedtheproportion
of statistical inconsistencies as the main outcome in this study.
Wider 95% confidence intervals of inconsistencies indicated
the possibility of insufficient statistical power in many cases
(fig 2). Therefore, statistically non-significant inconsistency
does not necessarily imply clinical consistency.
Inthecompleteabsenceofdirectevidence(acommonscenario
for using indirect comparison methods), our finding of higher
than expected prevalence of significant discrepancies (14% v
5% expected) between direct and indirect evidence suggests a
need for some caution in relying on indirect comparisons to
make firm conclusions.
To reduce the effect of random error, all relevant evidence
shouldbeincludedinasystematicreview.Systematicreviewers
are increasingly expected to combine all possible trial evidence
(both direct and indirect). Where some direct evidence exists,
this is mainly to improve the precision of the estimate of the
effect of treatment. Nevertheless, in our study the combined
evidence improved the precision to a level reaching statistical
significance in less than 4% (3/73) of such cases and cast
additional doubts on 36% (14/39) of direct evidence that would
have been considered conclusive (statistically significant).
Therefore,thecombinationofinconsistentevidencemayprovide
a misleading estimate of the effect of treatment. The statistical
consistency between different evidence should be properly
assessed, using the simple method used in this paper or more
complex methods designed for more extensive evidence
networks.
24 25
Conclusions
Significant inconsistency between the direct and indirect
comparisons may be more prevalent than has previously been
observed. It may be more common with subjectively assessed
outcomes, fewer trials included in analyses, and statistically
significantresultsfromeitherdirectorindirectcomparison.The
combinationofdirectandindirectestimatesinmixedtreatment
comparison should be done only after an adequate assessment
of the consistency of the evidence.
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RESEARCHTables
Table 1| Summary of basic characteristics of included trial networks
No (%) (n=112) Characteristics
Total No of trials involved
473 Direct comparison
1079 Adjusted indirect comparison
Source
85 (76) Cochrane systematic reviews
17 (15) Search of PubMed
10 (9) Previous study
Types of interventions
99 (88) Drug
8 (7) Surgical
2 (2) Psycho-educational
1 (1) Educational plus drug
1 (1) Physiotherapy
1 (1) Nutritional
Clinical field
24 (21) Infectious
16 (14) Circulatory
11 (10) Mental
8 (7) Gastrointestinal
9 (8) Pregnancy/childbirth
6 (5) Gynaecological
6 (5) Organ transplantation
5 (5) Neoplasm/cancer
4 (4) Dermatological
3 (3) Substance misuse/smoking
3 (3) Pain
17 (15) Other
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RESEARCHTable 2| Statistical inconsistency between direct and indirect comparison: results of overall and subgroup analyses
Difference between subgroups (P value) No (%) with statistically significant inconsistency Subgroups
16/112 (14) All trial networks
0.011 Source of trial networks:
16/85 (19) Cochrane review
0/27 (0) Other
1.000 Common comparator:
10/67 (15) Placebo or no treatment
6/45 (13) Active treatment
0.420 Nature of comparison:
7/56 (13) Different class/types
4/39 (10) Same class
5/17 (29) Same intervention
0.790 Intervention A v B:
10/65 (15) Newer or more intense
6/47 (13) Unclear
0.029 Outcome measures:
8/29 (28) Subjective
8/83 (10) Objective
0.018 Extent of heterogeneity*:
8/20 (40) I
2=0 (3-5 trials)
3/23 (13) I
2=0 (≥6 trials)
2/31 (7) I
2>0, <50%
3/36 (8) I
2≥50%
0.006 Total No of trials:
8/26 (31) 3-5
5/27 (19) 6-9
3/25 (12) 10-14
0/34 (0) ≥15
0.446 Indirect comparison in original Cochrane reviews:
1/13 (8) Explicitly done
15/72 (21) Not done
<0.001 Significant result by direct or indirect comparison:
15/48 (31) Significant
1/64 (2) Non-significant
*Largest I
2 among three meta-analyses in each trial network; I
2 not available in two trial networks.
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RESEARCHTable 3| Statistically significant results from direct and adjusted indirect comparisons
Total
Direct comparisons of A and B
Comparison methods Non-significant results Significant results (P<0.05)
112 73 39 All trial networks
Indirect comparisons of A and B:
23 9 14* Significant results
89 64 25 Non-significant results
Combination of direct and indirect estimates†:
28 3 25 Significant results
84 70 14 Non-significant results
*In one case (CD003262), both direct and indirect estimates were statistically significant but in opposite directions (see web appendix 1).
†DerSimonian-Laird random effects model used to combine direct and indirect estimates.
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RESEARCHFigures
Fig 1 Trial network used to investigate inconsistency between direct and indirect comparison. Each trial network consists
of three sets of independent trials: one set for direct comparison of A versus B and two sets for adjusted indirect comparison
of A versus B with C as common comparator.
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RESEARCHFig 2 Inconsistency between direct and indirect comparison: ratio of odds ratios (ROR) from 112 included trial networks.
ROR=1 indicates no difference in odds ratios between direct and indirect comparison
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RESEARCHFig 3 One sided funnel plot of (absolute) estimated inconsistency between direct and indirect comparison. Dotted line
indicates statistical significance at P=0.05
Fig 4 Inconsistency between direct and indirect comparisons of newer or more intense with older or less intense interventions.
Data from 65 relevant trial networks. Ratio of odds ratios (ROR) <1 indicates that effect of newer or more intense interventions
is greater in direct comparison than in indirect comparison
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